The cardiovascular actions of morphine and the endogenous opioid peptides.
Johnson
M W
MW
Mitch
W E
WE
Wilcox
C S
CS
D000818:Animals; D001127:Arginine Vasopressin / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D001923:Brain Chemistry; D002302:Cardiac Output / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects*; D004723:Endorphins / Q000032:analysis / Q000494:pharmacology*; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D007022:Hypotension / Q000139:chemically induced; D007275:Injections, Intravenous; D009020:Morphine / Q000494:pharmacology*; D009270:Naloxone / Q000494:pharmacology / Q000627:therapeutic use; D011957:Receptors, Opioid / Q000502:physiology*; D012769:Shock / Q000188:drug therapy; D001615:beta-Endorphin
D004723:Endorphins; D011957:Receptors, Opioid; D001127:Arginine Vasopressin; D009270:Naloxone; D001615:beta-Endorphin; D009020:Morphine